ヘルスケア受託製造市場の市場規模、シェア、動向分析レポート：タイプ別（医療機器、医薬品）、最終用途別（医療機器企業）、地域別、セグメント予測、2023年～2030年

ヘルスケア受託製造市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のヘルスケア受託製造市場規模は、予測期間中にCAGR 9.5%で拡大し、2030年までに3,475億米ドルに達する見込みです。

規制状況の変化と新興国へのオフショアリングの増加は、予測期間中のヘルスケア受託製造市場の成長を促進すると予測されています。例えば、2023年6月、FUJIFILM Diosynth Biotechnologiesは、東京に営業所を開設し、アジアの製薬会社やバイオテクノロジー企業に先端療法や生物製剤の開発・製造受託サービスを提供すると発表しました。

COVD-19のような感染症の出現により、多くの企業が需要の増加に対応するために生産を加速しようとしています。そのため、これらの企業はヘルスケアCMOを起用して生産プロセスを迅速化し、医療製品の需要増に対応するために全体的なコストを削減しています。COVID-19に対するワクチンと治療薬を開発するための世界の努力は、製薬会社が大規模にワクチン用量を製造しているため、多くの大規模CMOだけでなく小規模CMOにとっても最大の機会を生み出しています。したがって、パンデミックはこの業界に好影響を与えました。

高度な製品に対する需要の高まりも、業界規模を拡大する要因のひとつです。相手先ブランド製造業者（OEM）は、経済的利益を得るために、主に新興諸国において医療機器の製造活動を第三者にアウトソーシングしています。さらに、これらの地域では心臓疾患などの慢性疾患の患者が増加しており、市場成長にプラスの影響を与えています。償還制度の変更は、OEMによるコスト抑制策の採用を増加させると予想される主な要因の一部です。例えば、償還の問題が資金調達の目標に影響を与えないようにするため、機器メーカーは製品開発の初期段階で、規制戦略や臨床戦略と並行して綿密に計画された償還戦略を策定しています。

ヘルスケア受託製造市場レポートハイライト

• 医薬品分野は、低製造予算と高度に洗練された受託製造サービスの提供により、2022年には65.1%のシェアで市場を独占しました。
• 医療機器分野は、コスト削減と製品上市までの期間短縮を求めるOEMへの圧力が高まっているため、CAGR 9.7%で最も急成長が見込まれる分野です。
• 循環器科は、医療機器受託製造セグメントにおいて支配的なカテゴリーであり、2022年の収益シェアは20.6%です。
• アジア太平洋地域は2023年から2030年にかけて10.6%の好成長が見込まれているが、これは多数のサービスプロバイダーが存在すること、コストが低いこと、医療機器の需要が伸びていること別。
• 最終用途セグメントに基づくと、製薬・バイオ製薬企業カテゴリが2022年に55.6%と最も高い収益シェアを占めました。セグメントシェアが高いのは、主に世界中で生物製剤の承認率が上昇しているためで、それ別大量生産受託製造サービスの需要が高まっています。

目次

第1章 調査手法と範囲

• 市場セグメンテーションと範囲
  • セグメントの定義
  • タイプ
  • 最終用途
• 地域の範囲
• 推定・予測のタイムライン
• 目的
  • 目標-1
  • 目標-2
  • 目標-3
• 調査手法
• 情報調達
  • 購入したデータベース
  • GVRの内部データベース
  • 二次情報
  • 1次調査
• 情報またはデータ分析
  • データ分析モデル
• 市場の形成と検証
• モデル詳細
  • 商品フロー分析
  • 親市場分析
• 二次情報のリスト
• 略語のリスト

第2章 エグゼクティブサマリー

• 市場の見通し
• セグメントの見通し
• 競合考察

第3章 ヘルスケア受託製造市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助的な市場見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 業界の課題
• ヘルスケア受託製造市場分析ツール
  • 業界分析- ポーターズ
  • PESTEL分析
  • COVID-19の影響分析

第4章 ヘルスケア受託製造市場：タイプ別セグメント分析

• ヘルスケア受託製造：市場シェア分析、2022年および2030年
• 医療機器
  • 医療機器市場、2018～2030年（100万米ドル）
  • サービス
  • 治療領域
• 医薬品
  • 医薬品市場、2018-2030（100万米ドル）
  • サービス

第5章 ヘルスケア受託製造市場：最終用途別セグメント分析

• ヘルスケア受託製造：市場シェア分析、2022年および2030年
• 医療機器企業
  • 医療機器企業市場、2018年～2030年（100万米ドル）
• 製薬会社およびバイオ医薬品会社
  • 製薬およびバイオ医薬品企業市場、2018-2030（100万米ドル）
• その他
  • その他の市場、2018-2030（100万米ドル）

第6章 ヘルスケア受託製造市場：地域別分析

• 地域市場シェア分析、2022年および2030年
• 地域市場ダッシュボード
• 世界の地域市場のスナップショット
• 北米
  • 市場推計・予測、2018年から2030年（収益、100万米ドル）
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
  • ベルギー
  • オランダ
• アジア太平洋地域
  • 日本
  • インド
  • 中国
  • 韓国
  • オーストラリア
  • タイ
  • フィリピン
  • マレーシア
  • ニュージーランド
  • シンガポール
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
  • コロンビア
  • チリ
• MEA
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート
  • イスラエル

第7章 競合情勢

• 市場参入企業の分類
  • イノベーター
  • 市場リーダー
  • 新興企業
  • 企業の市場シェア分析、2022年
• 企業プロファイル
  • Nordson Corporation.
  • Integer Holdings Corporation
  • Jabil Inc.
  • Viant Technology LLC
  • FLEX LTD.
  • Celestica Inc.
  • Sanmina Corporation
  • Plexus Corp.
  • Phillips-Medisize
  • West Pharmaceutical Services, Inc.
  • Synecco Ltd.
  • Catalent, Inc.
  • Thermo Fisher Scientific Inc.
  • Recipharm AB.
  • Boehringer Ingelheim International GmbH
  • Lonza
  • Samsung Biologics
  • WuXi AppTec
  • FUJIFILM Diosynth Biotechnologies
  • Cambrex Corporation

第8章 KoLの解説/推奨事項

List of Tables

• Table 1 List of secondary sources
• Table 2 List of Abbreviations
• Table 3 North America Healthcare Contract Manufacturing market, by Countries, 2018 - 2030 (USD Million)
• Table 4 North America Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 5 North America Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 6 U.S. Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 7 U.S. Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 8 Canada Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 9 Canada Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 10 Europe Healthcare Contract Manufacturing market, by Countries, 2018 - 2030 (USD Million)
• Table 11 Europe Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 12 Europe Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 13 UK Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 14 UK Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 15 Germany Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 16 Germany Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 17 France Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 18 France Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 19 Italy Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 20 Italy Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 21 Spain Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 22 Spain Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 23 Denmark Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 24 Denmark Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 25 Sweden Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 26 Sweden Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 27 Norway Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 28 Norway Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 29 Belgium Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 30 Belgium Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 31 Netherlands Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 32 Netherlands Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 33 Asia Pacific Healthcare Contract Manufacturing market, by Countries, 2018 - 2030 (USD Million)
• Table 34 Asia Pacific Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 35 Asia Pacific Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 36 China Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 37 China Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 38 Japan Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 39 Japan Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 40 India Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 41 India Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 42 Australia Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 43 Australia Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 44 South Korea Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 45 South Korea Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 46 Philippines Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 47 Philippines Healthcare Contract Manufacturing market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 48 Malaysia Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 49 Malaysia Healthcare Contract Manufacturing market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 50 Thailand Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 51 Thailand Healthcare Contract Manufacturing market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 52 New Zealand Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 53 New Zealand Healthcare Contract Manufacturing market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 54 Singapore Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 55 Singapore Healthcare Contract Manufacturing market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 56 Latin America Healthcare Contract Manufacturing market, by Countries, 2018 - 2030 (USD Million)
• Table 57 Latin America Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 58 Latin America Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 59 Brazil Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 60 Brazil Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 61 Mexico Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 62 Mexico Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 63 Argentina Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 64 Argentina Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 65 Colombia Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 66 Colombia Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 67 Chile Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 68 Chile Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 69 Middle East and Africa Healthcare Contract Manufacturing market, by Countries, 2018 - 2030 (USD Million)
• Table 70 Middle East and Africa Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 71 Middle East and Africa Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 72 South Africa Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 73 South Africa Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 74 Saudi Arabia Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 75 Saudi Arabia Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 76 UAE Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 77 UAE Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 78 Israel Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 79 Israel Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
• Table 80 Kuwait Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
• Table 81 Kuwait Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Market research approaches
• Fig. 4 QFD modelling for market share assessment
• Fig. 5 Market formulation & validation
• Fig. 6 Commodity flow analysis
• Fig. 7 Primary research pattern
• Fig. 8 Primary interviews in North America
• Fig. 9 Primary interviews in Europe
• Fig. 10 Primary interviews in Asia Pacific
• Fig. 11 Primary interviews in Latin America
• Fig. 12 Primary interviews in MEA
• Fig. 13 Market Snapshot
• Fig. 14 Segment Snapshot
• Fig. 15 Competitive Landscape Snapshot
• Fig. 16 Healthcare Contract Manufacturing market segmentation
• Fig. 17 Parent market outlook (2022)
• Fig. 18 Related/ancillary market outlook (2022)
• Fig. 19 Market driver relevance analysis (Current & future impact)
• Fig. 20 Current shared End uses and outsourcing usage levels
• Fig. 21 Market restraint relevance analysis (Current & future impact)
• Fig. 22 Porter's five forces analysis
• Fig. 23 SWOT analysis, by a factor (political & legal, economic and technological)
• Fig. 24 Healthcare Contract Manufacturing Market Type outlook: Segment dashboard
• Fig. 25 Healthcare Contract Manufacturing : Type movement analysis
• Fig. 26 Medical devices market, 2018 - 2030 (USD Million)
• Fig. 27 Medical devices market, by service, 2018 - 2030 (USD Million)
• Fig. 28 Accessories manufacturing market, 2018 - 2030 (USD Million)
• Fig. 29 Assembly manufacturing market, 2018 - 2030 (USD Million)
• Fig. 30 Component manufacturing market, 2018 - 2030 (USD Million)
• Fig. 31 Device manufacturing market, 2018 - 2030 (USD Million)
• Fig. 32 Medical devices market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Fig. 33 Cardiology market, 2018 - 2030 (USD Million)
• Fig. 34 Diagnostic imaging market, 2018 - 2030 (USD Million)
• Fig. 35 Orthopedic market, 2018 - 2030 (USD Million)
• Fig. 36 IVD market, 2018 - 2030 (USD Million)
• Fig. 37 Ophthalmic market, 2018 - 2030 (USD Million)
• Fig. 38 General & plastic surgery market, 2018 - 2030 (USD Million)
• Fig. 39 Drug delivery market, 2018 - 2030 (USD Million)
• Fig. 40 Dental market, 2018 - 2030 (USD Million)
• Fig. 41 Endoscopy market, 2018 - 2030 (USD Million)
• Fig. 42 Diabetes care market, 2018 - 2030 (USD Million)
• Fig. 43 Others market, 2018 - 2030 (USD Million)
• Fig. 44 Pharmaceuticals market, 2018 - 2030 (USD Million)
• Fig. 45 Pharmaceuticals market, by Service, 2018 - 2030 (USD Million)
• Fig. 46 API/Bulk Drugs market, 2018 - 2030 (USD Million)
• Fig. 47 Advanced drug delivery formulations market, 2018 - 2030 (USD Million)
• Fig. 48 Packaging market, 2018 - 2030 (USD Million)
• Fig. 49 Finished dose formulation market, 2018 - 2030 (USD Million)
• Fig. 50 Finished dose formulation market, by type, 2018 - 2030 (USD Million)
• Fig. 51 Solid market, 2018 - 2030 (USD Million)
• Fig. 52 Liquid market, 2018 - 2030 (USD Million)
• Fig. 53 Semi-solid formulations market, 2018 - 2030 (USD Million)
• Fig. 54 Healthcare Contract Manufacturing Market End use outlook: Segment dashboard
• Fig. 55 Healthcare Contract Manufacturing : End use movement analysis
• Fig. 56 Medical device companies market, 2018 - 2030 (USD Million)
• Fig. 57 Pharmaceutical & Biopharmaceutical Companies market, 2018 - 2030 (USD Million)
• Fig. 58 Others market, 2018 - 2030 (USD Million)
• Fig. 59 Regional marketplace: Segment dashboard
• Fig. 60 Regional outlook, 2022 & 2030
• Fig. 61 North America market, 2018 - 2030 (USD Million)
• Fig. 62 U.S. market, 2018 - 2030 (USD Million)
• Fig. 63 Canada market, 2018 - 2030 (USD Million)
• Fig. 64 Europe market, 2018 - 2030 (USD Million)
• Fig. 65 Germany market, 2018 - 2030 (USD Million)
• Fig. 66 UK market, 2018 - 2030 (USD Million)
• Fig. 67 France market, 2018 - 2030 (USD Million)
• Fig. 68 Italy market, 2018 - 2030 (USD Million)
• Fig. 69 Spain market, 2018 - 2030 (USD Million)
• Fig. 70 Denmark market, 2018 - 2030(USD Million)
• Fig. 71 Sweden market, 2018 - 2030 (USD Million)
• Fig. 72 Norway market, 2018 - 2030 (USD Million)
• Fig. 73 Belgium market, 2018 - 2030 (USD Million)
• Fig. 74 Netherlands market, 2018 - 2030 (USD Million)
• Fig. 75 Asia Pacific market, 2018 - 2030 (USD Million)
• Fig. 76 China market, 2018 - 2030 (USD Million)
• Fig. 77 Japan market, 2018 - 2030 (USD Million)
• Fig. 78 India market, 2018 - 2030 (USD Million)
• Fig. 79 Australia market, 2018 - 2030 (USD Million)
• Fig. 80 South Korea market, 2018 - 2030 (USD Million)
• Fig. 81 Thailand market, 2018 - 2030 (USD Million)
• Fig. 82 Philippines market, 2018 - 2030 (USD Million)
• Fig. 83 Malaysia market, 2018 - 2030 (USD Million)
• Fig. 84 New Zealand market, 2018 - 2030 (USD Million)
• Fig. 85 Singapore market, 2018 - 2030 (USD Million)
• Fig. 86 Latin America market, 2018 - 2030 (USD Million)
• Fig. 87 Brazil market, 2018 - 2030 (USD Million)
• Fig. 88 Mexico market, 2018 - 2030 (USD Million)
• Fig. 89 Argentina market, 2018 - 2030 (USD Million)
• Fig. 90 Colombia market, 2018 - 2030 (USD Million)
• Fig. 91 Chile market, 2018 - 2030 (USD Million)
• Fig. 92 Middle East & Africa market, 2018 - 2030 (USD Million)
• Fig. 93 South Africa market, 2018 - 2030 (USD Million)
• Fig. 94 Saudi Arabia market, 2018 - 2030 (USD Million)
• Fig. 95 UAE market, 2018 - 2030 (USD Million)
• Fig. 96 Kuwait market, 2018 - 2030 (USD Million)
• Fig. 97 Israel market, 2018 - 2030 (USD Million)

Healthcare Contract Manufacturing Market Growth & Trends

The global healthcare contract manufacturing market size is expected to reach USD 347.5 billion by 2030, expanding at a CAGR of 9.5% during the forecast period, according to a new report by Grand View Research, Inc. The changing regulatory landscape coupled with rising offshoring to emerging countries is anticipated to propel the healthcare contract manufacturing market growth over the forecast period. For instance, in June 2023, FUJIFILM Diosynth Biotechnologies announced to have a commercial office in Tokyo, offering contract development and manufacturing services for advanced therapies and biologics to Asian pharmaceutical and biotechnology companies.

Due to the emergence of infections, such as COVD-19 many organizations are attempting to accelerate production to meet the growing demand. Thus, these companies are appointing healthcare CMOs to speed up their production processes, as well as reduce their overall costs to meet the increasing demand for medical products. The worldwide effort to develop a vaccine and therapeutic agent against COVID-19 has created the greatest opportunity for many large as well as small CMOs as the pharmaceutical companies are manufacturing vaccine doses on large scale. Hence, the pandemic had a positive impact on this industry.

Increasing demand for advanced products is another factor driving the industry scale. Original Equipment Manufacturers (OEMs) are outsourcing the manufacturing activities of medical devices to third parties, mainly in developing countries to gain economic benefits. Furthermore, these regions are witnessing rising cases of chronic conditions such as heart disorders, thereby positively affecting the market growth. Changes in reimbursement schemes are some of the major factors anticipated to increase the adoption of cost containment measures by OEMs. For instance, to prevent reimbursement issues from impacting financing goals, device manufacturers are developing a well-planned reimbursement strategy in parallel with their regulatory and clinical strategies in the early phases of product development.

Healthcare Contract Manufacturing Market Report Highlights

• The pharmaceutical segment dominated the market with a share of 65.1% in 2022 owing to a low manufacturing budget and highly sophisticated contract manufacturing service offerings
• The medical devices segment is expected to be the fastest-growing segment with a CAGR of 9.7% owing to increasing pressure on OEMs to reduce costs and enhance the timeline for taking a product to market
• Cardiology is the dominant category in the medical device contract manufacturing segment, with a revenue share of 20.6% in 2022, owing to the rising demand for cardiovascular devices as a result of the increasing prevalence of associated heart conditions
• Asia Pacific is expected to witness lucrative growth of 10.6% from 2023 to 2030, owing to the presence of a large number of service providers, lower costs, and growing demand for medical devices in the region
• Based on end use segment, the pharmaceutical and biopharmaceutical companies category held the highest revenue share of 55.6% in 2022. High segment shares are mainly due to the increasing rate of biologics approval across the globe, thereby boosting demand for its bulk production contract manufacturing services

Table of Content

Chapter 1. Research Methodology And Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment Definitions
  • 1.1.2. Type
  • 1.1.3. End Use
• 1.2. Regional Scope
• 1.3. Estimates And Forecast Timeline
• 1.4. Objectives
  • 1.4.1. Objective-1
  • 1.4.2. Objective-2
  • 1.4.3. Objective-3
• 1.5. Research Methodology
• 1.6. Information Procurement
  • 1.6.1. Purchased Database
  • 1.6.2. GVR's Internal Database
  • 1.6.3. Secondary Sources
  • 1.6.4. Primary Research
• 1.7. Information Or Data Analysis
  • 1.7.1. Data Analysis Models
• 1.8. Market Formulation & Validation
• 1.9. Model Details
  • 1.9.1. Commodity Flow Analysis
  • 1.9.2. Parent Market Analysis
• 1.10. List Of Secondary Sources
• 1.11. List Of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Healthcare Contract Manufacturing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Implementation of international standards by contract manufacturers
    • 3.2.1.2. Drug shortage driving the demand for pharmaceutical development
    • 3.2.1.3. Commercial success of biologics for clinical use
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Regulatory and legal compliance
    • 3.2.2.2. Threat of information loss
  • 3.2.3. Industry Challenges
    • 3.2.3.1. Managing relationships
• 3.3. Healthcare Contract Manufacturing Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat Of New Entrant
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Healthcare Contract Manufacturing Market: Type Segment Analysis

• 4.1 Healthcare Contract Manufacturing: Market Share Analysis, 2022 & 2030
• 4.2 Medical Device
  • 4.2.1 Medical device market, 2018 - 2030 (USD Million)
  • 4.2.2 Service
    • 4.2.2.1 Accessories manufacturing
    • 4.2.2.1.1 Accessories manufacturing market, 2018 - 2030 (USD Million)
    • 4.2.2.2 Assembly manufacturing
    • 4.2.2.2.1 Assembly manufacturing market, 2018 - 2030 (USD Million)
    • 4.2.2.3 Component manufacturing
    • 4.2.2.3.1 Component manufacturing market, 2018 - 2030 (USD Million)
    • 4.2.2.4 Device manufacturing
    • 4.2.2.4.1 Device manufacturing market, 2018 - 2030 (USD Million)
  • 4.2.3 Therapeutic area
    • 4.2.3.1 Cardiology
    • 4.2.3.1.1 Cardiology market, 2018 - 2030 (USD Million)
    • 4.2.3.2 Diagnostic imaging
    • 4.2.3.2.1 Diagnostic imaging market, 2018 - 2030 (USD Million)
    • 4.2.3.3 Orthopedic
    • 4.2.3.3.1 Orthopedic market, 2018 - 2030 (USD Million)
    • 4.2.3.4 IVD
    • 4.2.3.4.1 IVD market, 2018 - 2030 (USD Million)
    • 4.2.3.5 Ophthalmic
    • 4.2.3.5.1 Ophthalmic market, 2018 - 2030 (USD Million)
    • 4.2.3.6 General & plastic surgery
    • 4.2.3.6.1 General & plastic surgery market, 2018 - 2030 (USD Million)
    • 4.2.3.7 Drug delivery
    • 4.2.3.7.1 Drug delivery market, 2018 - 2030 (USD Million)
    • 4.2.3.8 Dental
    • 4.2.3.8.1 Dental market, 2018 - 2030 (USD Million)
    • 4.2.3.9 Endoscopy
    • 4.2.3.9.1 Endoscopy market, 2018 - 2030 (USD Million)
    • 4.2.3.10 Diabetes care
    • 4.2.3.10.1 Diabetes care market, 2018 - 2030 (USD Million)
    • 4.2.3.11 Others
    • 4.2.3.11.1 Others market, 2018 - 2030 (USD Million)
• 4.3 Pharmaceutical
  • 4.3.1 Pharmaceutical market, 2018 - 2030 (USD Million)
  • 4.3.2 Service
    • 4.3.2.1 API/bulk drugs
    • 4.3.2.1.1 API/bulk drugs market, 2018 - 2030 (USD Million)
    • 4.3.2.2 Advanced drug delivery formulations
    • 4.3.2.2.1 Advanced drug delivery formulations market, 2018 - 2030 (USD Million)
    • 4.3.2.3 Packaging
    • 4.3.2.3.1 Packaging market, 2018 - 2030 (USD Million)
    • 4.3.2.4 Finished dose formulations
    • 4.3.2.4.1 Finished dose formulations market, 2018 - 2030 (USD Million)
    • 4.3.2.4.2 Solid
    • 4.3.2.4.2.1 Solid market, 2018 - 2030 (USD Million)
    • 4.3.2.4.3 Liquid
    • 4.3.2.4.3.1 Liquid market, 2018 - 2030 (USD Million)
    • 4.3.2.4.4 Semisolid formulations
    • 4.3.2.4.4.1 Semisolid formulations market, 2018 - 2030 (USD Million)

Chapter 5. Healthcare Contract Manufacturing Market: End Use Segment Analysis

• 5.1 Healthcare Contract Manufacturing: Market Share Analysis, 2022 & 2030
• 5.2 Medical Device Companies
  • 5.2.1 Medical device companies market, 2018 - 2030 (USD Million)
• 5.3 Pharmaceutical & Biopharmaceutical Companies
  • 5.3.1 Pharmaceutical & Biopharmaceutical Companies market, 2018 - 2030 (USD Million)
• 5.4 Others
  • 5.4.1 Others market, 2018 - 2030 (USD Million)

Chapter 6. Healthcare Contract Manufacturing Market: Regional Analysis

• 6.1. Regional Market Share Analysis, 2022 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. North America
  • 6.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
  • 6.4.2. U.S.
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Competitive Scenario
    • 6.4.2.3. Regulatory Framework
    • 6.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
  • 6.4.3. Canada
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Competitive Scenario
    • 6.4.3.3. Regulatory Framework
    • 6.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
• 6.5. Europe
  • 6.5.1. UK
    • 6.5.1.1. Key Country Dynamics
    • 6.5.1.2. Competitive Scenario
    • 6.5.1.3. Regulatory Framework
    • 6.5.1.4. UK Market Estimates and Forecasts, 2018 - 2030
  • 6.5.2. Germany
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. Germany Market Estimates and Forecasts, 2018 - 2030
  • 6.5.3. France
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. France Market Estimates and Forecasts, 2018 - 2030
  • 6.5.4. Italy
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Competitive Scenario
    • 6.5.4.3. Regulatory Framework
    • 6.5.4.4. Italy Market Estimates and Forecasts, 2018 - 2030
  • 6.5.5. Spain
    • 6.5.5.1. Key Country Dynamics
    • 6.5.5.2. Competitive Scenario
    • 6.5.5.3. Regulatory Framework
    • 6.5.5.4. Spain Market Estimates and Forecasts, 2018 - 2030
  • 6.5.6. Denmark
    • 6.5.6.1. Key Country Dynamics
    • 6.5.6.2. Competitive Scenario
    • 6.5.6.3. Regulatory Framework
    • 6.5.6.4. Denmark Market Estimates and Forecasts, 2018 - 2030
  • 6.5.7. Sweden
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Competitive Scenario
    • 6.5.7.3. Regulatory Framework
    • 6.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030
  • 6.5.8. Norway
    • 6.5.8.1. Key Country Dynamics
    • 6.5.8.2. Competitive Scenario
    • 6.5.8.3. Regulatory Framework
    • 6.5.8.4. Norway Market Estimates and Forecasts, 2018 - 2030
  • 6.5.9. Belgium
    • 6.5.9.1. Key Country Dynamics
    • 6.5.9.2. Competitive Scenario
    • 6.5.9.3. Regulatory Framework
    • 6.5.9.4. Belgium Market Estimates and Forecasts, 2018 - 2030
  • 6.5.10. Netherlands
    • 6.5.10.1. Key Country Dynamics
    • 6.5.10.2. Competitive Scenario
    • 6.5.10.3. Regulatory Framework
    • 6.5.10.4. Netherlands Market Estimates and Forecasts, 2018 - 2030
• 6.6. Asia Pacific
  • 6.6.1. Japan
    • 6.6.1.1. Key Country Dynamics
    • 6.6.1.2. Competitive Scenario
    • 6.6.1.3. Regulatory Framework
    • 6.6.1.4. Japan Market Estimates and Forecasts, 2018 - 2030
  • 6.6.2. India
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. India Market Estimates and Forecasts, 2018 - 2030
  • 6.6.3. China
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. China Market Estimates and Forecasts, 2018 - 2030
  • 6.6.4. South Korea
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Competitive Scenario
    • 6.6.4.3. Regulatory Framework
    • 6.6.4.4. South Korea Market Estimates and Forecasts, 2018 - 2030
  • 6.6.5. Australia
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Competitive Scenario
    • 6.6.5.3. Regulatory Framework
    • 6.6.5.4. Australia Market Estimates and Forecasts, 2018 - 2030
  • 6.6.6. Thailand
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Competitive Scenario
    • 6.6.6.3. Regulatory Framework
    • 6.6.6.4. Thailand Market Estimates and Forecasts, 2018 - 2030
  • 6.6.7. Philippines
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Competitive Scenario
    • 6.6.7.3. Regulatory Framework
    • 6.6.7.4. Philippines Market Estimates and Forecasts, 2018 - 2030
  • 6.6.8. Malaysia
    • 6.6.8.1. Key Country Dynamics
    • 6.6.8.2. Competitive Scenario
    • 6.6.8.3. Regulatory Framework
    • 6.6.8.4. Malaysia Market Estimates and Forecasts, 2018 - 2030
  • 6.6.9. New Zealand
    • 6.6.9.1. Key Country Dynamics
    • 6.6.9.2. Competitive Scenario
    • 6.6.9.3. Regulatory Framework
    • 6.6.9.4. New Zealand Market Estimates and Forecasts, 2018 - 2030
  • 6.6.10. Singapore
    • 6.6.10.1. Key Country Dynamics
    • 6.6.10.2. Competitive Scenario
    • 6.6.10.3. Regulatory Framework
    • 6.6.10.4. Singapore Market Estimates and Forecasts, 2018 - 2030
• 6.7. Latin America
  • 6.7.1. Brazil
    • 6.7.1.1. Key Country Dynamics
    • 6.7.1.2. Competitive Scenario
    • 6.7.1.3. Regulatory Framework
    • 6.7.1.4. Brazil Market Estimates and Forecasts, 2018 - 2030
  • 6.7.2. Mexico
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Competitive Scenario
    • 6.7.2.3. Regulatory Framework
    • 6.7.2.4. Mexico Market Estimates and Forecasts, 2018 - 2030
  • 6.7.3. Argentina
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Competitive Scenario
    • 6.7.3.3. Regulatory Framework
    • 6.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030
  • 6.7.4. Colombia
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Competitive Scenario
    • 6.7.4.3. Regulatory Framework
    • 6.7.4.4. Colombia Market Estimates and Forecasts, 2018 - 2030
  • 6.7.5. Chile
    • 6.7.5.1. Key Country Dynamics
    • 6.7.5.2. Competitive Scenario
    • 6.7.5.3. Regulatory Framework
    • 6.7.5.4. Chile Market Estimates and Forecasts, 2018 - 2030
• 6.8. MEA
  • 6.8.1. South Africa
    • 6.8.1.1. Key Country Dynamics
    • 6.8.1.2. Competitive Scenario
    • 6.8.1.3. Regulatory Framework
    • 6.8.1.4. South Africa Market Estimates and Forecasts, 2018 - 2030
  • 6.8.2. Saudi Arabia
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Competitive Scenario
    • 6.8.2.3. Regulatory Framework
    • 6.8.2.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • 6.8.3. UAE
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Competitive Scenario
    • 6.8.3.3. Regulatory Framework
    • 6.8.3.4. UAE Market Estimates and Forecasts, 2018 - 2030
  • 6.8.4. Kuwait
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Competitive Scenario
    • 6.8.4.3. Regulatory Framework
    • 6.8.4.4. Kuwait Market Estimates and Forecasts, 2018 - 2030
  • 6.8.5. Israel
    • 6.8.5.1. Key Country Dynamics
    • 6.8.5.2. Competitive Scenario
    • 6.8.5.3. Regulatory Framework
    • 6.8.5.4. Israel Market Estimates and Forecasts, 2018 - 2030

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
  • 7.1.1. Innovators
  • 7.1.2. Market Leaders
  • 7.1.3. Emerging Players
  • 7.1.4. Company Market Share Analysis, 2022
• 7.2. Company Profiles
  • 7.2.1 Nordson Corporation.
    • 7.2.1.1 Company overview
    • 7.2.1.2 Financial performance
    • 7.2.1.3 Service benchmarking
    • 7.2.1.4 Strategic initiatives
  • 7.2.2 Integer Holdings Corporation
    • 7.2.2.1 Company overview
    • 7.2.2.2 Financial performance
    • 7.2.2.3 Service benchmarking
    • 7.2.2.4 Strategic initiatives
  • 7.2.3 Jabil Inc.
    • 7.2.3.1 Company overview
    • 7.2.3.2 Financial performance
    • 7.2.3.3 Service benchmarking
    • 7.2.3.4 Strategic initiatives
  • 7.2.4 Viant Technology LLC
    • 7.2.4.1 Company overview
    • 7.2.4.2 Service benchmarking
    • 7.2.4.3 Strategic initiatives
  • 7.2.5 FLEX LTD.
    • 7.2.5.1 Company overview
    • 7.2.5.2 Financial performance
    • 7.2.5.3 Service benchmarking
    • 7.2.5.4 Strategic initiatives
  • 7.2.6 Celestica Inc.
    • 7.2.6.1 Company overview
    • 7.2.6.2 Financial performance
    • 7.2.6.3 Service benchmarking
    • 7.2.6.4 Strategic initiatives
  • 7.2.7 Sanmina Corporation
    • 7.2.7.1 Company overview
    • 7.2.7.2 Financial performance
    • 7.2.7.3 Service benchmarking
    • 7.2.7.4 Strategic initiatives
  • 7.2.8 Plexus Corp.
    • 7.2.8.1 Company overview
    • 7.2.8.2 Financial performance
    • 7.2.8.3 Service benchmarking
    • 7.2.8.4 Strategic initiatives
  • 7.2.9 Phillips-Medisize
    • 7.2.9.1 Company overview
    • 7.2.9.2 Service benchmarking
    • 7.2.9.3 Strategic initiatives
  • 7.2.10 West Pharmaceutical Services, Inc.
    • 7.2.10.1 Company overview
    • 7.2.10.2 Financial performance
    • 7.2.10.3 Service benchmarking
    • 7.2.10.4 Strategic initiatives
  • 7.2.11 Synecco Ltd.
    • 7.2.11.1 Company overview
    • 7.2.11.2 Service benchmarking
  • 7.2.12 Catalent, Inc.
    • 7.2.12.1 Company overview
    • 7.2.12.2 Financial performance
    • 7.2.12.3 Service benchmarking
    • 7.2.12.4 Strategic initiatives
  • 7.2.13 Thermo Fisher Scientific Inc.
    • 7.2.13.1 Company overview
    • 7.2.13.2 Financial performance
    • 7.2.13.3 Service benchmarking
    • 7.2.13.4 Strategic initiatives
  • 7.2.14 Recipharm AB.
    • 7.2.14.1 Company overview
    • 7.2.14.2 Financial performance
    • 7.2.14.3 Service benchmarking
    • 7.2.14.4 Strategic initiatives
  • 7.2.15 Boehringer Ingelheim International GmbH
    • 7.2.15.1 Company overview
    • 7.2.15.2 Financial performance
    • 7.2.15.3 Service benchmarking
    • 7.2.15.4 Strategic initiatives
  • 7.2.16 Lonza
    • 7.2.16.1 Company overview
    • 7.2.16.2 Financial performance
    • 7.2.16.3 Service benchmarking
    • 7.2.16.4 Strategic initiatives
  • 7.2.17 Samsung Biologics
    • 7.2.17.1 Company overview
    • 7.2.17.2 Financial performance
    • 7.2.17.3 Service benchmarking
    • 7.2.17.4 Strategic initiatives
  • 7.2.18 WuXi AppTec
    • 7.2.18.1 Company overview
    • 7.2.18.2 Financial performance
    • 7.2.18.3 Service benchmarking
    • 7.2.18.4 Strategic initiatives
  • 7.2.19 FUJIFILM Diosynth Biotechnologies
    • 7.2.19.1 Company overview
    • 7.2.19.2 Financial performance
    • 7.2.19.3 Service benchmarking
    • 7.2.19.4 Strategic initiatives
  • 7.2.20 Cambrex Corporation
    • 7.2.20.1 Company overview
    • 7.2.20.2 Financial performance
    • 7.2.20.3 Service benchmarking
    • 7.2.20.4 Strategic initiatives

Chapter 8. KoL Commentary/Recommendations